GSK-Nuvalent merger waiting period expires in the US (correct*)
MLex Summary: Nuvalent disclosed in a filing with the US Securities and Exchange Commission that the Hart-Scott-Rodino Act waiting period for its deal with GSK expired in the US....To view the full article, register now.
Already a subscriber? Click here to view full article